Vertex Pharmaceuticals, Inc’s recently made public that its Director CARNEY LLOYD acquired Company’s shares for reported $0.34 million on Nov 20 ’25. In the deal valued at $426.36 per share,800 shares were bought.
Then, Atkinson Edward Morrow III sold 2,500 shares, generating $1,086,450 in total proceeds. Upon selling the shares at $434.58, the EVP, Chief Technical Ops. Off. now owns 16,852 shares.
Before that, LEIDEN JEFFREY M sold 53,604 shares. Vertex Pharmaceuticals, Inc shares valued at $23,624,306 were divested by the Executive Chairman at a price of $440.72 per share. As a result of the transaction, LEIDEN JEFFREY M now holds 24,026 shares, worth roughly $10.19 million.
Scotiabank initiated its Vertex Pharmaceuticals, Inc [VRTX] rating to a Sector outperform in a research note published on November 13, 2025; the price target was $495. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late September from “a Market perform” to “an Outperform”. Raymond James began covering VRTX with “Mkt perform” recommendation on September 03, 2025. Wells Fargo revised its rating on August 06, 2025. It rated VRTX as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of VRTX
On Monday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock fall -0.65% to $424.0. Over the last five days, the stock has lost -2.31%. Vertex Pharmaceuticals, Inc shares have fallen nearly -6.03% since the year began. Nevertheless, the stocks have risen 5.29% over the past one year. While a 52-week high of $519.68 was reached on 03/14/25, a 52-week low of $362.50 was recorded on 08/11/25.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 421.07, which if violated will result in even more drops to 418.13. On the upside, there is a resistance level at 429.74. A further resistance level may holdings at 435.48.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-10-31, growing by 0.57 million shares to a total of 4.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 3.56 million shares. There was a rise of 13.91%, which implies that there is a positive sentiment for the stock.
